#biotech

[ follow ]

Everything to know about Vivek Ramaswamy, co-lead of the Department of Government Efficiency with Elon Musk

Vivek Ramaswamy's transition from a failed presidential bid to a key position in Trump's government highlights his rapid ascent in political influence.
#innovation

#NYCtech Week in Review: 8/18/24 - 8/24/24

NYC Tech is witnessing significant startup funding, indicating a robust entrepreneurial ecosystem.

#NYCtech Week in Review: 5/26/24 - 6/1/24

Diverse NYC startup fundings and events include Gameto's $33M biotech raise, Authentic Insurance's $11M, Matter Bio's $7M, and Clasp's $6.4M funding.

Prolific Machines, with a $55M Series B, shines 'light' on a better way to grow lab proteins for food and medicine | TechCrunch

Prolific Machines has developed a bioreactor using light to control cell growth, aiming to revolutionize manufacturing of cultivated meat and medicine.

Visibuilt Raises 1.3 Million to Transform Asphalt Production with Mycelium

Visibuilt raises €1.3 million to develop visiBIT, a sustainable binder that could replace traditional bitumen in asphalt production and reduce CO2 emissions.

Many scientists are neurodivergent. Architects are finally starting to build labs designed for them

Traditional lab designs may inhibit research by not accommodating the diverse needs of neurodivergent scientists.

In other news this week: Voiceline secures 2.4M, FRVR bags 11.5M, YC's Cosine codifies human reasoning and more - Silicon Canals

This week saw startups securing significant funding in tech, energy, and biotech sectors, focusing on innovative solutions and sustainable practices.

#NYCtech Week in Review: 8/18/24 - 8/24/24

NYC Tech is witnessing significant startup funding, indicating a robust entrepreneurial ecosystem.

#NYCtech Week in Review: 5/26/24 - 6/1/24

Diverse NYC startup fundings and events include Gameto's $33M biotech raise, Authentic Insurance's $11M, Matter Bio's $7M, and Clasp's $6.4M funding.

Prolific Machines, with a $55M Series B, shines 'light' on a better way to grow lab proteins for food and medicine | TechCrunch

Prolific Machines has developed a bioreactor using light to control cell growth, aiming to revolutionize manufacturing of cultivated meat and medicine.

Visibuilt Raises 1.3 Million to Transform Asphalt Production with Mycelium

Visibuilt raises €1.3 million to develop visiBIT, a sustainable binder that could replace traditional bitumen in asphalt production and reduce CO2 emissions.

Many scientists are neurodivergent. Architects are finally starting to build labs designed for them

Traditional lab designs may inhibit research by not accommodating the diverse needs of neurodivergent scientists.

In other news this week: Voiceline secures 2.4M, FRVR bags 11.5M, YC's Cosine codifies human reasoning and more - Silicon Canals

This week saw startups securing significant funding in tech, energy, and biotech sectors, focusing on innovative solutions and sustainable practices.
moreinnovation
#layoffs

Biotech giant Gilead lays off 104 from Bay Area HQ, including execs

Gilead Sciences is reducing its workforce amid a strategic reallocation of resources for future product launches.

Bay Area biotech firm Genentech cuts 93 workers just months after last layoff

Genentech's recent layoffs of 93 employees are part of ongoing workforce evaluations due to unmet research goals and restructuring needs.

Biotech giant Gilead lays off 104 from Bay Area HQ, including execs

Gilead Sciences is reducing its workforce amid a strategic reallocation of resources for future product launches.

Bay Area biotech firm Genentech cuts 93 workers just months after last layoff

Genentech's recent layoffs of 93 employees are part of ongoing workforce evaluations due to unmet research goals and restructuring needs.
morelayoffs
#stock-market

Stocks making the biggest moves premarket: Amazon, Apple, Atlassian and more

Amazon reports strong earnings driven by cloud and advertising growth.
Atlassian sees major stock surge after exceeding earnings expectations.
Intel beats earnings and revenue estimates, boosting investor confidence.
Abbott's stock rises after jury ruling in a liability case.

Warren Buffett Back for More, Plus Big Insider Buying at Biotechs Too

Insider buying signals confidence in stock performance, especially during uncertain market conditions.
Berkshire Hathaway continues to show strong investment activity in key sectors, such as media and biotech.

Stocks making the biggest moves premarket: Amazon, Apple, Atlassian and more

Amazon reports strong earnings driven by cloud and advertising growth.
Atlassian sees major stock surge after exceeding earnings expectations.
Intel beats earnings and revenue estimates, boosting investor confidence.
Abbott's stock rises after jury ruling in a liability case.

Warren Buffett Back for More, Plus Big Insider Buying at Biotechs Too

Insider buying signals confidence in stock performance, especially during uncertain market conditions.
Berkshire Hathaway continues to show strong investment activity in key sectors, such as media and biotech.
morestock-market
#ai

'Where we are today in biology AI is similar to GPT in 2020': An interview with the CEO of Africa's biggest AI startup | TechCrunch

Instadeep has advanced its AI capabilities significantly while aligning with BioNTech's therapeutic goals post-acquisition.

Arzeda is using AI to design proteins for artificial sweeteners and more | TechCrunch

AI is revolutionizing protein design, enabling the creation of sustainable alternatives for various products.
Arzeda leverages proprietary data and advanced AI techniques to transition from research to commercial application.

SoftBank forms AI healthcare JV in Japan with Tempus | TechCrunch

SoftBank Group and Tempus form joint venture in Japan to develop AI-powered personalized medical services, starting with oncology.

Archon emerges from stealth with $20M and 'antibody cages' to power up drug development | TechCrunch

Archon Biosciences aims to revolutionize antibody treatments through innovative protein 'cages' that improve drug binding and efficacy.

'Where we are today in biology AI is similar to GPT in 2020': An interview with the CEO of Africa's biggest AI startup | TechCrunch

Instadeep has advanced its AI capabilities significantly while aligning with BioNTech's therapeutic goals post-acquisition.

Arzeda is using AI to design proteins for artificial sweeteners and more | TechCrunch

AI is revolutionizing protein design, enabling the creation of sustainable alternatives for various products.
Arzeda leverages proprietary data and advanced AI techniques to transition from research to commercial application.

SoftBank forms AI healthcare JV in Japan with Tempus | TechCrunch

SoftBank Group and Tempus form joint venture in Japan to develop AI-powered personalized medical services, starting with oncology.

Archon emerges from stealth with $20M and 'antibody cages' to power up drug development | TechCrunch

Archon Biosciences aims to revolutionize antibody treatments through innovative protein 'cages' that improve drug binding and efficacy.
moreai
#investment

Hollywood's Olivia Wilde launches a VC firm | TechCrunch

Olivia Wilde launches Proximity Ventures, targeting early and growth-stage investments in consumer and enterprise sectors.

Dutch immunotherapy company Pan Cancer T bags 4.2M - Silicon Canals

Rotterdam-based Pan Cancer T secured €4.25M in seed extension, advancing T cell therapies for solid cancers, with support from new and existing investors.

Hollywood's Olivia Wilde launches a VC firm | TechCrunch

Olivia Wilde launches Proximity Ventures, targeting early and growth-stage investments in consumer and enterprise sectors.

Dutch immunotherapy company Pan Cancer T bags 4.2M - Silicon Canals

Rotterdam-based Pan Cancer T secured €4.25M in seed extension, advancing T cell therapies for solid cancers, with support from new and existing investors.
moreinvestment

Other Barks & Bites for Friday, October 18: OpenAI Outlines Defensive Patent Strategy; Microsoft Files Opposition in Lawsuit Alleging Illegal Buyer's Cartel for Patent Licenses; Moderna Under Fire for Spikevax Vaccine Tech

Trilobio wins injunction in a trade secret case against a former employee, underscoring the importance of IP protection in biotech.
#investing

Prediction: This Will Be the Best-Performing Growth Stock Over the Next 5 Years

Investors are shifting focus to growth stocks as interest rates decline, with a mix of established companies and biotech options leading the pack.

3 Penny Stocks To Buy With Just $750

Penny stocks can yield high returns but involve significant risk; focus on biotech for multiple catalysts.
Investing in biotech penny stocks offers more potential due to their development timelines and regulatory advancements.

Prediction: This Will Be the Best-Performing Growth Stock Over the Next 5 Years

Investors are shifting focus to growth stocks as interest rates decline, with a mix of established companies and biotech options leading the pack.

3 Penny Stocks To Buy With Just $750

Penny stocks can yield high returns but involve significant risk; focus on biotech for multiple catalysts.
Investing in biotech penny stocks offers more potential due to their development timelines and regulatory advancements.
moreinvesting
#drug-discovery

Heart disease is the world's biggest killer - this Cambridge Uni spinout is using AI to find new treatments | TechCrunch

AI is transforming drug discovery, particularly for cardiovascular diseases.
CardiaTec raised $6.5 million to enhance cardiovascular disease treatments through AI.
CVDs cause 17.9 million deaths annually, highlighting a major health crisis.

French biotech Generare speeds up hunt for new drugs by cloning natural molecules | TechCrunch

Generare raised €5 million to enhance its scalable methods for discovering natural compounds for drug development.

Recursion to merge with Exscientia - Silicon Canals

The merger between Recursion and Exscientia aims to combine their expertise to accelerate drug design and development.

Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start developing drugs | TechCrunch

Biotech investors tap into generative AI for drug discovery.

French biotech firm Generare secures 5M - Silicon Canals

Generare secures €5M funding to enhance biotechnology for drug discovery by leveraging microbial DNA.

Heart disease is the world's biggest killer - this Cambridge Uni spinout is using AI to find new treatments | TechCrunch

AI is transforming drug discovery, particularly for cardiovascular diseases.
CardiaTec raised $6.5 million to enhance cardiovascular disease treatments through AI.
CVDs cause 17.9 million deaths annually, highlighting a major health crisis.

French biotech Generare speeds up hunt for new drugs by cloning natural molecules | TechCrunch

Generare raised €5 million to enhance its scalable methods for discovering natural compounds for drug development.

Recursion to merge with Exscientia - Silicon Canals

The merger between Recursion and Exscientia aims to combine their expertise to accelerate drug design and development.

Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start developing drugs | TechCrunch

Biotech investors tap into generative AI for drug discovery.

French biotech firm Generare secures 5M - Silicon Canals

Generare secures €5M funding to enhance biotechnology for drug discovery by leveraging microbial DNA.
moredrug-discovery
#funding

Triveni Bio Raises $115M Series B Financing to Advance Antibody Treatments for I&I Disorders

Triveni Bio Inc. raised $115 million to accelerate its antibody therapies for immune and inflammatory disorders, focusing on novel pathways and advanced treatment efficacy.

Calif. biotech company that raised $325 million shuts down, lays off all workers

EFFECTOR Therapeutics, a biotech company focusing on cancer research, is shutting down after failing to bring a product to market despite raising significant funds.

Finnish biotech firm NADMED raises 3.5M in Series A round

NADMED secures €3.5 million in funding to expand its health diagnostics technology, focused on measuring crucial metabolites associated with age-related diseases.

Triveni Bio Raises $115M Series B Financing to Advance Antibody Treatments for I&I Disorders

Triveni Bio Inc. raised $115 million to accelerate its antibody therapies for immune and inflammatory disorders, focusing on novel pathways and advanced treatment efficacy.

Calif. biotech company that raised $325 million shuts down, lays off all workers

EFFECTOR Therapeutics, a biotech company focusing on cancer research, is shutting down after failing to bring a product to market despite raising significant funds.

Finnish biotech firm NADMED raises 3.5M in Series A round

NADMED secures €3.5 million in funding to expand its health diagnostics technology, focused on measuring crucial metabolites associated with age-related diseases.
morefunding

A surfer without a degree is worth $16 billion after his biotech company's stock soared 1,100% in a year

Bob Duggan, an uneducated entrepreneur, became a biotech billionaire through Summit Therapeutics, exemplifying success outside traditional academic pathways.

Exclusive: Connected fitness startup EGYM is ramping up with $200m at a $1.2B+ valuation

EGYM secures over $200 million funding to expand tech-driven fitness solutions in new markets and enhance AI-based training tools.

Exclusive: Synex founder, once detained at the border with a 80-pound magnet, is building portable MRIs to test glucose

Synex Medical is developing a portable MRI for non-invasive glucose testing, potentially revolutionizing diabetes care.

Lyon-based Brenus Pharma secures 22.2M to advance cancer vaccine trials: Here's how - Silicon Canals

Brenus Pharma secures €22.2M Series A funding to advance cancer vaccine development, targeting metastatic colorectal cancer and expanding into other gastric tumors.

3 Penny Stocks To Buy With Just $50

Investing in penny stocks can yield high returns, but risks must be carefully managed.

A newly built office tower in downtown Durham is turning to speculative lab space

Developers are adapting to increased vacancy rates by creating lab space to attract tenants.
Roxboro's speculative lab spaces aim to support smaller biotech firms amidst leasing challenges.

Building a culture of GxP excellence in biotech - London Business News | Londonlovesbusiness.com

GxP is essential not only for compliance but for embedding product safety and public trust into the core operations of biotech organizations.

Tech and biotech layoffs jolt Bay Area with hundreds of lost jobs

The ongoing layoffs in Bay Area tech and biotech sectors reflect a troubling trend, with over 45,700 jobs cut since 2022.
from New York Post
3 months ago

Feds are still sending 'mad scientist' millions to China - and keeping it from Congress

The U.S. continues to fund risky research in adversarial countries, raising significant national security concerns.

The AlleyWatch Startup Daily Funding Report: 5/29/2024

Gameto raised $33M in Series B funding for women's reproductive health and infertility.

COVID-19 test maker Cue Health once worth $2.3B lays off entire company and shuts down

Cue Health, a San Diego biotech firm supplying COVID-19 test kits, shut down due to FDA warning on false results, resulting in employee layoffs.
#data-science

Francine Bennett uses data science to make AI more responsible | TechCrunch

TechCrunch launching interview series on AI-focused women academics.
Francine Bennett involved in AI work in biotech and data science.

Machine Learning for Biotech, Biopharma, and ML Safety Sessions Coming to ODSC East 2024

Machine learning is crucial in safety, security, biotech, and pharma industries at ODSC East 2024.

Francine Bennett uses data science to make AI more responsible | TechCrunch

TechCrunch launching interview series on AI-focused women academics.
Francine Bennett involved in AI work in biotech and data science.

Machine Learning for Biotech, Biopharma, and ML Safety Sessions Coming to ODSC East 2024

Machine learning is crucial in safety, security, biotech, and pharma industries at ODSC East 2024.
moredata-science

Startups Weekly: What goes up must come down | TechCrunch

Microsoft absorbs Inflection, leaving it in a precarious position
Microbiome startups may lack scientific rigor

This futurist predicts that everybody will have an AI digital twin

Super cycles are extended periods of booming demand driven by structural change.
Current super cycle is propelled by AI, biotech, and wearables leading to reshaping of human civilization.

A Pill That Kills Ticks Is a Promising New Weapon Against Lyme Disease

A human pill for tick prevention like those for pets is in development by Tarsus Pharmaceuticals.
The pill showed in a trial to kill ticks on people and provide protection for up to 30 days.

What's News, Breaking: Friday, February 2, 2024

A new biotech workforce development program launched in New York City, offering training and career development opportunities in the rapidly growing biotechnology sector.
The program is open to individuals pursuing employment in the life sciences ecosystem, even if they don't have backgrounds in STEM.

Dutch biotech startup bags 22M for proprietary generative AI model

Cradle, a biotech software startup, is using generative AI to help biologists engineer improved proteins.
The use of AI reduces R&D time and costs, allowing projects to proceed at twice the speed compared to the industry average.

San Jose tech and biotech incubator hub gains traction and tenants

BioCube in San Jose attracts tech and biotech companies, provides a complete ecosystem for startups to grow in place.

How gene-therapy treated mice in space may help shape the science of vision loss diseases

Biotech Oculogenex received FDA endorsement for therapy in treating eye-wasting disease.
from TechCrunch
5 months ago

Enveda raises $55M to combine ancient remedies with AI for drug discovery | TechCrunch

Modern pharmaceuticals have roots in natural remedies used by ancestors.
AI can expedite the process of discovering new medicines from nature.
[ Load more ]